Item 2.02 Results of Operations and Financial Condition.
On
The information in this Item 2.02 is unaudited and preliminary, and does not
present all information necessary for an understanding of the Company's
financial condition as of
Item 7.01. Regulation FD Disclosure.
The disclosure in Item 2.02 above is hereby incorporated by reference into this Item 7.01.
The slides presented by
The information in this report and Exhibit 99.1 to this report is furnished pursuant to Items 2.02 and 7.01 and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Items 2.02 and 7.01 of this report.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1Sarepta Therapeutics, Inc. Presentation at the 39th Annual J.P.Morgan Healthcare Conference , datedJanuary 11, 2021 104 The cover page from this Current Report on Form 8-K ofSarepta Therapeutics, Inc. , formatted in Inline XBRL and included as Exhibit 101 2
--------------------------------------------------------------------------------
© Edgar Online, source